Catalyst Wire Dossier Catalyst Wire Dossier

Tecemotide (L-BLP25)

tecemotide · Merck KGaA
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tecemotide (L-BLP25), covering 2015-08-18 to 2017-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer [Phase 3]

See pricing